← FDA Drug Approvals (Drugs@FDA)
CARBIDOPA, LEVODOPA AND ENTACAPONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2022-01-25
Drug application
- FDA Application #
ANDA213212- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Generic name
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Active ingredients
- CARBIDOPA; ENTACAPONE; LEVODOPA
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RISING
- Manufacturer
- Rising Pharma Holdings, Inc.
- First approval
- 2022-01-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown